))
Michael Levin and the race to reverse MS neurodegeneration
Manage episode 303136864 series 2876289
内容由Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine提供。所有播客内容（包括剧集、图形和播客描述）均由 Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Dr Michael Levin is a neuroscientist unravelling the mysteries of nerve degeneration in Multiple Sclerosis patients.
He's also Saskatchewan's inaugural MS Clinical Research Chair, whose team recently won a New Frontiers in Research Fund award.
"In my lifetime, there's been a dramatic change in how we treat MS," said Levin. "There's a lot of hope when people come into the clinic."
But after taking steroids for a number of years, many MS patients still relapse.
"It's this kind of slow degenerative kind of nickel and diming of people's function that we would really like to nip in the bud," said Levin.
His task now is to find a drug that re-shapes a key protein involved with nerve degeneration, sending that protein back into its normal position.
In this episode, hear why this could be a game-changer for MS patients across Saskatchewan and the world.
85集单集
分享
